IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalidomide Add-On to Rituximab vs Placebo + Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)
作者
Laurie Helen Sehn,Christian W. Scholz,Stefano Luminari,Antonio Salar,Björn Engelbrekt Wahlin,Ajay K. Gopal,Christophe Marc Bonnet,Marek Trněný,Shankara Paneesha,Oliver Manzke,Francis Séguy,Di Li,Kai Hübel